Showing 5501-5510 of 23224 results for "".
The Benefit of a 24-Day Oral Contraceptive
https://reachmd.com/programs/clinicians-roundtable/the-benefit-of-a-24-day-oral-contraceptive/2540/What are the motivating reasons behind development of a 24 dose/cycle oral contraceptive? Dr. Leon Speroff discusses the distinction of the 24-day contraceptive in regards to breakthrough bleeding, follicular growth and development, and endometrial thickness. Dr. Speroff also covers the 24-day conHormone Therapy and Coronary Heart Disease
https://reachmd.com/programs/clinicians-roundtable/hormone-therapy-and-coronary-heart-disease/2539/Where does post-menopausal hormone replacement therapy stand? Dr. Leon Speroff navigates the findings of the Women's Health Initiative (WHI), discussing the alleged elevated risk of coronary heart disease coupled with post-menopausal hormone replacement therapy.Intolerable Waits for a Commodity in Short Supply
https://reachmd.com/programs/clinicians-roundtable/intolerable-waits-for-a-commodity-in-short-supply/2499/Michele Goodwin, Professor of Law at the University of Minnesota and recent author of "Black Markets: The Supply and Demand of Body Parts" discusses what can be done to shorten the wait for organ transplants. Current solutions such as matching programs, solicitations and altruism still lead to poorManaging Statin Intolerant Patients
https://reachmd.com/programs/lipid-luminations/managing-statin-intolerant-patients/2487/Dr. Larry Kaskel welcomes Dr. Peter Jones to Lipid Luminations. Dr. Jones is Associate Professor in the Center for Cardiovascular Disease Prevention of the Methodist DeBakey Heart Center and Baylor College of Medicine in Houston. They will discuss how common statin intolerance is and what other drugMoving Beyond SSRI's
https://reachmd.com/programs/clinicians-roundtable/moving-beyond-ssris/2478/Today we have many options to treat depression: the SSRIs, Cymbalta, Effexor, Emsam, Wellbutrin, just to name a few. How do you know when to move beyond the SSRIs? When is it time to refer to a psychiatrist? What if there are no psychiatrists available to your patients? Host Dr. Leslie Lundt welcRealities and Limitations of SSRIs
https://reachmd.com/programs/clinicians-roundtable/realities-and-limitations-of-ssris/2477/SSRIs are among the most common medications prescribed in the world. What have we learned since Prozac was introduced in 1987? Psychopharmacologist Dr. Stephen Ellen discusses pros and cons of SSRIs with host Dr. Leslie Lundt.Johns Hopkins Colleges Program: A Physician Look
https://reachmd.com/programs/clinicians-roundtable/johns-hopkins-colleges-program-a-physicians-look/2436/What is the faculty experience like at the Johns Hopkins Colleges Program, a new learning environment at the Johns Hopkins Medical School? Join Dr. Hoover Adger, Sabin College Leader and a committed faculty member who applied to be a part of this innovative medical school approach. Dr. Bill RutenberBoosting Practice Revenue in Tough Economic Times
https://reachmd.com/programs/clinicians-roundtable/boosting-practice-revenue-in-tough-economic-times/2426/Almost every day, you hear or read about people working more for less, and doctors are no different with employers, insurers and government payers looking for ways to slow rising health costs. So how do doctors maximize revenue in this challenging environment? Tim Dugan, co-founder of private equityTort Reform's Momentum and its Benefit to Doctors
https://reachmd.com/programs/clinicians-roundtable/tort-reforms-momentum-and-its-benefit-to-doctors/2416/Potentially better rates in the wake of tort reform that have capped certain damages are more in the offering than in recent years, but is the momentum going to continue to spread across the country in states where tort reform has stalled? Dr. Richard Anderson, chairman and chief executive officer oA Doctor's Opinion on Pharma Education
https://reachmd.com/programs/clinicians-roundtable/a-doctors-opinion-on-pharma-education/2399/Dr. Daniel Carlat has written in a New York Times article called, “Dr. Drug Rep”, that allowing pharmaceutical companies to sponsor medical education leads to many bad things, including biased education, corrupt physicians, and, ultimately, harm to our patients. Host Dr. Leslie Lundt listens to what